IDEAYA Biosciences (IDYA) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $8.84 million.
For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kodiak Gas Services, Inc. (KGS) Reports Q2 EPS of $0.55
- Barrick Gold (ABX) Tops Q2 EPS by 4c
- Funko (FNKO) Tops Q2 EPS by 46c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
